Is Merrimack Pharmaceuticals Inc (MACK) a Leader in the Healthcare Sector?

Merrimack Pharmaceuticals Inc (MACK) is around the top of the Healthcare sector according to InvestorsObserver. MACK received an overall rating of 73, which means that it scores higher than 73% of stocks. Additionally, Merrimack Pharmaceuticals Inc scored a 71 in the Healthcare sector, ranking it higher than 71% of stocks in that sector.

MACK has an Overall Score of 73. Find out what this means to you and get the rest of the rankings on MACK!

See Full MACK Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Merrimack Pharmaceuticals Inc Stock Today?

Merrimack Pharmaceuticals Inc (MACK) stock has fallen -0.08% while the S&P 500 has gained 0.01% as of 12:37 PM on Monday, Nov 27. MACK is lower by -$0.01 from the previous closing price of $12.87 on volume of 7,496 shares. Over the past year the S&P 500 has gained 15.03% while MACK has gained 7.89%. MACK lost -$0.10 per share the over the last 12 months. Click Here to get the full Stock Report for Merrimack Pharmaceuticals Inc stock.